IMM40H Phase I Dose Escalation and Expansion
Clinical trial NCT05549557 · UNKNOWN
Trial details
- NCT number
- NCT05549557
- Sponsor
- ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2023-10-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.